Search Results - "Jarugula, V"
-
1
Results From the IQ-CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase
Published in Clinical pharmacology and therapeutics (01-04-2015)“…The QT effects of five “QT‐positive” and one negative drug were tested to evaluate whether exposure–response analysis can detect QT effects in a small study…”
Get full text
Journal Article -
2
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes
Published in International journal of clinical pharmacology and therapeutics (01-07-2008)“…Vildagliptin is a selective inhibitor of dipeptidyl peptidase IV (DPP-4) that improves glycemic control and pancreatic b-cell function in patients with Type 2…”
Get full text
Journal Article -
3
Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects
Published in International journal of clinical pharmacology and therapeutics (01-05-2008)“…To assess the bioequivalence of vildagliptin/metformin fixed-dose combination tablets (at doses of 50/500, 50/850 and 50/1,000 mg) with free combination of the…”
Get full text
Journal Article -
4
Labeling of drugs that interact with oral contraceptives
Published in Clinical pharmacology and therapeutics (01-02-2005)“…Background Labeling should clearly describe drug‐drug interactions (DDI) between oral contraceptives (OCs) and other drugs. The purpose of this study was to…”
Get full text
Journal Article -
5
Nonlinear pharmacokinetics of 5-fluorouracil in rats
Published in Journal of pharmaceutical sciences (01-06-1997)“…The effects of dose on the pharmacokinetics of 5-fluorouracil (5-FU) were investigated following intravenous administration of 5-FU at 10, 50, and 100 mg/kg to…”
Get more information
Journal Article -
6
The IQ-CSRC Prospective Clinical Phase 1 Study: "Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?"
Published in Annals of noninvasive electrocardiology (01-01-2014)“…A collaboration between the Consortium for Innovation and Quality in Pharmaceutical Development and the Cardiac Safety Research Consortium has been formed to…”
Get full text
Journal Article -
7
Pharmacokinetics of 5-carboranyl-2'-deoxyuridine in rats
Published in Journal of pharmaceutical sciences (01-12-1994)“…The pharmacokinetics of 5-carboranyl-2'-deoxyuridine (CDU) after intravenous administration of 25 mg/kg was investigated in rats. The uptake of CDU into brain…”
Get more information
Journal Article -
8
PIII-49Comparison of ethinyl estradiol exposure among approved contraceptive products in the U.S
Published in Clinical pharmacology and therapeutics (01-02-2006)Get full text
Journal Article -
9
PIII-49
Published in Clinical pharmacology and therapeutics (01-02-2006)“…BACKGROUND The risk of thromboembolic events in women using hormonal contraceptive products is a concern. Doses of ethinyl estradiol (EE) have been…”
Get full text
Journal Article -
10
Experience evaluating QT prolongation data
Published in Clinical pharmacology and therapeutics (01-02-2004)“…A preliminary concept paper (http://cdernet.cder.fda.gov/QTWG/QT%20Workshop/qt4jam.pdf) advises on the design of effective QT assessment studies. We aimed to…”
Get full text
Journal Article -
11
High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma
Published in Journal of chromatography. B, Biomedical applications (23-02-1996)“…A rapid, sensitive and reproducible ion-pair, reversed-phase high-performance liquid chromatographic (HPLC) method was developed to simultaneously quantitate…”
Get full text
Journal Article